Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologics

References

• Gottschalk U, Brorson K, Shukla AA. Innovation in biomanufacturing: the only way forward. Pharm Bioprocessing 2013; 1:141-57; http://dx.doi.org/10.4155/pbp.13.17
   Google Scholar
• McLaughlin J, Banerjee A. Biopharmaceutical manufacturing and flexible design: what does the future hold? Pharm Bioprocessing 2014; 2:215-7; http://dx.doi.org/10.4155/pbp.14.20
   Google Scholar
• International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Quality Risk Management Q9. 2006. Available at: http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html
   Google Scholar
• International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Pharmaceutical Quality Systems (Q10). 2008. Available at: http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html
   Google Scholar
• International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Pharmaceutical Development Q8(R2). 2009. Available at: http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html
   Google Scholar
• Aksu B, Paradkar A, de Matas M, Ozer O, Guneri T, York P. Quality by design approach: application of artificial intelligence techniques of tablets manufactured by direct compression. AAPS PharmSciTech 2012; 13:1138-46; PMID:22956056; http://dx.doi.org/10.1208/s12249-012-9836-x
   PubMed Web of Science ®Google Scholar
• Kessel M. The problems with today's pharmaceutical business–an outsider's view. Nature Biotechnol 2011; 29:27-33; http://dx.doi.org/10.1038/nbt.1748
   PubMed Web of Science ®Google Scholar
• Aksu B, De Beer T, Folestad S, Ketolainen J, Linden H, Lopes JA, de Matas M, Oostra W, Rantanen J, Weimer M. Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT). Eur J Pharm Sci 2012; 47:402-5; PMID:22749874; http://dx.doi.org/10.1016/j.ejps.2012.06.009
   PubMed Web of Science ®Google Scholar
• Luciani F, Galluzzo S, Gaggioli A, Kruse NA, Venneugues P, Schneider CK, Pini C, Melchiorri D. Implementing quality by design for biotech products: Are regulators on track? mAbs 2015; 7:451-5; PMID:25853461; http://dx.doi.org/10.1080/19420862.2015.1023058
   PubMed Web of Science ®Google Scholar
• Yu LX, Amidon G, Khan MA, Hoag SW, Polli J, Raju GK, Woodcock J. Understanding pharmaceutical quality by design. AAPS J 2014; 16:771-83; PMID:24854893; http://dx.doi.org/10.1208/s12248-014-9598-3
   PubMed Web of Science ®Google Scholar
• Beck A, Wagner-Rousset E, Ayoub D, Van Dorsselaer A, Sanglier-Cianferani S. Characterization of therapeutic antibodies and related products. Anal Chem 2013; 85:715-36; PMID:23134362; http://dx.doi.org/10.1021/ac3032355
   PubMed Web of Science ®Google Scholar
• Kaltashov IA, Bobst CE, Abzalimov RR, Wang G, Baykal B, Wang S. Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics. Biotechnol Adv 2012; 30:210-22; PMID:21619926; http://dx.doi.org/10.1016/j.biotechadv.2011.05.006
   PubMed Web of Science ®Google Scholar
• Sandra K, Vandenheede I, Sandra P. Modern chromatographic and mass spectrometric techniques for protein biopharmaceutical characterization. J Chromatogr A 2014; 1335:81-103; PMID:24365115; http://dx.doi.org/10.1016/j.chroma.2013.11.057
   PubMed Web of Science ®Google Scholar
• Zhang Z. Large-scale identification and quantification of covalent modifications in therapeutic proteins. Anal Chem 2009; 81:8354-64; PMID:19764700; http://dx.doi.org/10.1021/ac901193n
   PubMed Web of Science ®Google Scholar
• Kozlowski S, Nashabeh W, Schenerman M, Anderson H, Blumentals I, Ho K, Mahtre R, Rellahan B, Vinci V, McLeod L. QbD for Biologics: Learning from the Product Development and Realization (A-MAb) Case Study and the FDA OBP Pilot Program. BioProcess International 2012; 10:18-29;
   Google Scholar
• Rathore AS, Winkle H. Quality by design for biopharmaceuticals. Nat Biotechnol 2009; 27:26-34; PMID:19131992; http://dx.doi.org/10.1038/nbt0109-26
   PubMed Web of Science ®Google Scholar
• Aggarwal RS. What's fueling the biotech engine-2012 to 2013. Nat Biotechnol 2014; 32:32-9; PMID:24406926; http://dx.doi.org/10.1038/nbt.2794
   PubMed Web of Science ®Google Scholar
• Walsh G. Biopharmaceutical benchmarks 2014. Nat Biotechnol 2014; 32:992-1000; PMID:25299917; http://dx.doi.org/10.1038/nbt.3040
   PubMed Web of Science ®Google Scholar
• Reichert JM. Antibodies to watch in 2014. mAbs 2014; 6:5-14; PMID:24284914; http://dx.doi.org/10.4161/mabs.27333
   PubMed Web of Science ®Google Scholar
• Valliere-Douglass J, Wallace A, Balland A. Separation of populations of antibody variants by fine tuning of hydrophobic-interaction chromatography operating conditions. J Chromatogr A 2008; 1214:81-9; PMID:19012891; http://dx.doi.org/10.1016/j.chroma.2008.10.078
   PubMed Web of Science ®Google Scholar
• Zhao SS, Chen DD. Applications of capillary electrophoresis in characterizing recombinant protein therapeutics. Electrophoresis 2014; 35:96-108; PMID:24123141; http://dx.doi.org/10.1002/elps.201300372
   PubMed Web of Science ®Google Scholar
• Federici M, Lubiniecki A, Manikwar P, Volkin DB. Analytical lessons learned from selected therapeutic protein drug comparability studies. Biologicals 2013; 41:131-47; PMID:23146362; http://dx.doi.org/10.1016/j.biologicals.2012.10.001
   PubMed Web of Science ®Google Scholar
• Brady LJ, Velayudhan J, Visone DB, Daugherty KC, Bartron JL, Coon M, Cornwall C, Hinckley PJ, Connell-Crowley L. The criticality of high-resolution N-linked carbohydrate assays and detailed characterization of antibody effector function in the context of biosimilar development. mAbs 2015; 7(3):562-70; PMID:25898160; http://dx.doi.org/10.1080/19420862.2015.1016692
   PubMed Web of Science ®Google Scholar
• Goetze AM, Liu YD, Zhang Z, Shah B, Lee E, Bondarenko PV, Flynn GC. High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans. Glycobiology 2011; 21:949-59; PMID:21421994; http://dx.doi.org/10.1093/glycob/cwr027
   PubMed Web of Science ®Google Scholar
• Jefferis R. Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action. Trends Pharmacol Sci 2009; 30:356-62; PMID:19552968; http://dx.doi.org/10.1016/j.tips.2009.04.007
   PubMed Web of Science ®Google Scholar
• Shah B, Jiang XG, Chen L, Zhang Z. LC-MS/MS peptide mapping with automated data processing for routine profiling of N-glycans in immunoglobulins. J Am Soc Mass Spectrom 2014; 25:999-1011; PMID:24664809; http://dx.doi.org/10.1007/s13361-014-0858-3
   PubMed Web of Science ®Google Scholar
• Arora T, Green R, Mercer J, Tsang P, Casais M, Feldman S, Look J, Lubinecky T, Mezzatesta J, Pluschke A, et al. Quality by design for biotechnology products. Biopharm Int 2009; 22:26–36
   Google Scholar
• Brady LJ, Scott RA, Balland A. An optimized approach to the rapid assessment and detection of sequence variants in recombinant protein products. Anal Bioanal Chem 2015; 407:3851-60; PMID:25795027; http://dx.doi.org/10.1007/s00216-015-8618-1
   PubMed Web of Science ®Google Scholar
• Zhang Z, Shah B, Bondarenko PV. G/U and certain wobble position mismatches as possible main causes of amino acid misincorporations. Biochemistry 2013; 52:8165-76; PMID:24128183; http://dx.doi.org/10.1021/bi401002c
   PubMed Web of Science ®Google Scholar
• Schenauer MR, Flynn GC, Goetze AM. Profiling the effects of process changes on residual host cell proteins in biotherapeutics by mass spectrometry. Biotechnol Prog 2013; 29:951-7; PMID:23696295; http://dx.doi.org/10.1002/btpr.1748
   PubMed Web of Science ®Google Scholar
• Pais DA, Carrondo MJ, Alves PM, Teixeira AP. Towards real-time monitoring of therapeutic protein quality in mammalian cell processes. Curr Opin Biotechnol 2014; 30C:161-7; PMID:25035940; http://dx.doi.org/10.1016/j.copbio.2014.06.019
   PubMed Web of Science ®Google Scholar
• Rathore A, Krull IS, Mendhe R. Analytical Tools for enabling process analytical technology (PAT) applications in biotechnology. LCGC North Am 2012; 30:52-63
   Web of Science ®Google Scholar